Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage

Neurosurgery

Volumn 68, Issue 4, 2011, Pages 1118-1123

  Schöller, Karsten ^a   Feiler, Sergej ^a   Anetsberger, Stephanie ^a   Kim, Seong Woong ^a,b   Plesnila, Nikolaus ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Bradykinin; Brain edema; Early brain injury; Mouse; Subarachnoid hemorrhage

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN EDEMA; BRAIN WATER; CONTROLLED STUDY; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; MORTALITY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PUNCTURE; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; WEIGHT REDUCTION;

ANIMALS; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SUBARACHNOID HEMORRHAGE;

EID: 79952901303     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820a0024     Document Type: Article

References (43)

1. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25(7):1342-1347. (Pubitemid 24198577)
2. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33(5):1225-1232. (Pubitemid 34520392)
3. Laszlo FA, Varga C, Doczi T. Cerebral oedema after subarachnoid haemorrhage: pathogenetic significance of vasopressin. Acta Neurochir (Wien). 1995;133 (3-4):122-133.
4. Doczi T. The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage: clinical and experimental studies. Acta Neurochir (Wien ). 1985;77(3-4):110-132. (Pubitemid 16214427)
5. Schöller K, Trinkl A, Klopotowski M, et al. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res. 2007;1142:237-246. (Pubitemid 46413192)
6. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88(3):227-249. (Pubitemid 34302973)
7. Zausinger S. Bradykinin receptor antagonists in cerebral ischemia and trauma. IDrugs. 2003;6(10):970-975. (Pubitemid 37327974)
8. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1995;26(1):1-16.
9. Rodi D, Couture R, Ongali B, Simonato M. Targeting kinin receptors for the treatment of neurological diseases. Curr Pharm Des. 2005;11(10):1313-1326. (Pubitemid 40458276)
10. Unterberg A, Wahl M, Baethmann A. Effects of bradykinin on permeability and diameter of pial vessels in vivo. J Cereb Blood Flow Metab. 1984;4(4):574-585. (Pubitemid 15222302)
11. Groger M, Lebesgue D, Pruneau D, et al. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2005;25(8): 978-989. (Pubitemid 41061713)
12. Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand- Verrecchia C. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. Br J Pharmacol. 2003;139(8):1539-1547. (Pubitemid 37174669)
13. Trabold R, Eros C, Zweckberger K, et al. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2010;30(1):130-139.
14. Su J, Cui M, Tang Y, Zhou H, Liu L, Dong Q. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. Biochem Biophys Res Commun. 2009;388(2):205-211.
15. Hellal F, Pruneau D, Palmier B, et al. Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury. J Neurotrauma. 2003;20(9):841-851. (Pubitemid 37159066)
16. Kasuya H, Shimizu T, Okada T, Takahashi K, Summerville T, Kitamura K. Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage. Acta Neurochir (Wien ). 1988;91(3-4):120-125.
17. Thal SC, Sporer S, Schmid-Elsaesser R, Plesnila N, Zausinger S. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome. Crit Care Med. 2009;37(7):2228-2234.
18. Pesquero JB, Araujo RC, Heppenstall PA, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A. 2000;97(14):8140-8145. (Pubitemid 30460786)
19. Borkowski JA, Ransom RW, Seabrook GR, et al. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem. 1995;270(23):13706-13710.
20. Thal SC, Plesnila N. Non-invasive intraoperative monitoring of blood pressure and arterial Pco2 during surgical anesthesia in mice. J Neurosci Methods. 2007;159(2):261-267. (Pubitemid 44920263)
21. Feiler S, Friedrich B, Scholler K, Thal SC, Plesnila N. Standardized induction of subarachnoid hemorrhage in mice by intracranial pressure monitoring. J Neurosci Methods. 2010;190(2):164-170.
22. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28(3): 660-664. (Pubitemid 27118394)
23. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26(11):1341-1353. (Pubitemid 44629883)
24. Kamii H, Kato I, Kinouchi H, et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke. 1999;30(4):867-871.
25. Thal SC, Sporer S, Klopotowski M, et al. Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats: laboratory investigation. J Neurosurg. 2009;111(5):988-994.
26. Doczi T, Joo F, Adam G, Bozoky B, Szerdahelyi P. Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery. 1986;18(6):733-739. (Pubitemid 16067827)
27. Germano A, d'Avella D, Imperatore C, Caruso G, Tomasello F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien). 2000;142(5):575-580.
28. Wahl M, Young AR, Edvinsson L, Wagner F. Effects of bradykinin on pial arteries and arterioles in vitro and in situ. J Cereb Blood Flow Metab. 1983;3(2):231-237. (Pubitemid 13025508)
29. Unterberg A, Baethmann AJ. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma. J Neurosurg. 1984;61(1):87-96. (Pubitemid 14081297)
30. Francel PC. Bradykinin and neuronal injury. J Neurotrauma. 1992;9(Suppl 1): S27-S45.
31. Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res. 2002;950(1-2):268-278. (Pubitemid 35253939)
32. Lumenta DB, Plesnila N, Klasner B, et al. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Brain Res. 2006;1069(1):227-234. (Pubitemid 43145917)
33. Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A. Therapeutical efficacy of a novel non-peptide bradykinin B2 receptor antagonist on brain edema formation and ischemic tissue damage in focal cerebral ischemia. Acta Neurochir Suppl. 2003;86:205-207.
34. Klasner B, Lumenta DB, Pruneau D, Zausinger S, Plesnila N. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats. Neurochem Int. 2006;49(5):442-447. (Pubitemid 44189639)
35. Relton JK, Beckey VE, Hanson WL, Whalley ET. CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke. 1997;28(7):1430-1436. (Pubitemid 27300683)
36. Schulz J, Plesnila N, Eriskat J, Stoffel M, Pruneau D, Baethmann A. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats. Acta Neurochir Suppl. 2000;76:137-139.
37. Plesnila N, Schulz J, Stoffel M, Eriskat J, Pruneau D, Baethmann A. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats. J Neurotrauma. 2001;18(10):1049-1058. (Pubitemid 33000675)
38. Gorlach C, Hortobagyi T, Hortobagyi S, et al. Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury. J Neurotrauma. 2001;18(8):833-838. (Pubitemid 32769779)
39. Araujo RC, Kettritz R, Fichtner I, Paiva AC, Pesquero JB, Bader M. Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol Chem. 2001;382(1):91-95.
40. McLean PG, Ahluwalia A, Perretti M. Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J Exp Med. 2000;192(3):367-380. (Pubitemid 30629162)
41. Austinat M, Braeuninger S, Pesquero JB, et al. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke. 2009;40(1):285-293.
42. Hanson WL, McCullough RG, Selig WM, et al. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors. Immunopharmacology. 1996;33(1-3):191-193. (Pubitemid 26247930)
43. Lehmberg J, Beck J, Baethmann A, Uhl E. Bradykinin antagonists reduce leukocyte- endothelium interactions after global cerebral ischemia. J Cereb Blood Flow Metab. 2003;23(4):441-448. (Pubitemid 36403026)